Grassie M A, McCallum J F, Guzzi F, Magee A I, Milligan G, Parenti M
Department of Biochemistry, University of Glasgow, U.K.
Biochem J. 1994 Sep 15;302 ( Pt 3)(Pt 3):913-20. doi: 10.1042/bj3020913.
Plasmids containing cDNAs encoding either the wild-type guanine-nucleotide-binding protein G(o)1 alpha or the palmitoylation-negative cysteine-3-to-serine (C3S) mutant of G(o)1 alpha were transfected into Rat 1 cells, and clones stably expressing immunoreactivity corresponding to these polypeptides were isolated. Clones C5B (expressing wild-type G(o)1 alpha) and D3 (expressing the mutant form) were selected for detailed study. Immunoprecipitation of whole cell lysates of each clone labelled with either [3H]palmitate or [3H]myristate demonstrated incorporation of [3H]myristate into both wild-type and the C3S mutant of G(o)1 alpha, but that incorporation of hydroxylamine-sensitive [3H]palmitate was restricted to the wild type. When membrane and cytoplasmic fractions were prepared from cells of either the C5B or D3 clones, although immunodetection of wild-type G(o)1 alpha was observed only in the membrane fraction, the C3S mutant was present in both membrane and cytoplasmic fractions. Furthermore, a significant proportion of the C3S G(o)1 alpha immunoreactivity was also detected in the cytoplasmic fraction if immunoprecipitation of recently synthesized G(o)1 alpha was performed from fractions derived from cells pulse-labelled with [35S]Trans label. Pretreatment of cells of both clones C5B and D3 with pertussis toxin led to complete ADP-ribosylation of the cellular population of G(o)1 alpha in both cell types, irrespective of whether the polypeptide was subsequently found in the membrane or cytoplasmic fraction following cellular disruption. By contrast, separation of membrane and cytoplasmic fractions before pertussis-toxin-catalysed [32P]ADP-ribosylation allowed modification only of the membrane-associated G(o)1 alpha (whether wild-type or the C3S mutant). This labelling was decreased substantially by incubation of the membranes with guanosine 5'-[beta gamma-imido]triphosphate. No cytoplasmic G-protein beta subunit was detected immunologically, and the non-membrane-associated C3S G(o)1 alpha from D3 cells migrated as an apparently monomeric 40 kDa protein on a Superose 12 gel-filtration column. Membrane-associated wild-type and C3S G(o)1 alpha appeared to interact with guanine nucleotides with similar affinity, as no alteration in the dose-response curves for guanine-nucleotide-induced maintenance of a stable 37 kDa tryptic fragment was noted for the two forms of G(o)1 alpha. Chemical depalmitoylation of membranes of clone C5B with neutral 1 M hydroxylamine caused a release of some 25-30% of each of G(o)1 alpha, Gi2 alpha and Gq alpha/G11 alpha from the membranes. Equivalent treatment of D3 cells caused an equivalent release of Gi2 alpha and Gq alpha/G11 alpha, but was unable to cause any appreciable release of the CS3 form of G(o)1 alpha, which was membrane-bound.
将编码野生型鸟嘌呤核苷酸结合蛋白G(o)1α或G(o)1α的棕榈酰化阴性半胱氨酸3突变为丝氨酸(C3S)突变体的cDNA质粒转染到大鼠1细胞中,并分离出稳定表达与这些多肽相对应的免疫反应性的克隆。选择克隆C5B(表达野生型G(o)1α)和D3(表达突变形式)进行详细研究。用[3H]棕榈酸酯或[3H]肉豆蔻酸酯标记的每个克隆的全细胞裂解物的免疫沉淀表明,[3H]肉豆蔻酸酯掺入野生型和G(o)1α的C3S突变体中,但对羟胺敏感的[3H]棕榈酸酯的掺入仅限于野生型。当从C5B或D3克隆的细胞中制备膜和细胞质组分时,尽管仅在膜组分中观察到野生型G(o)1α的免疫检测,但C3S突变体存在于膜和细胞质组分中。此外,如果从用[35S]Trans label脉冲标记的细胞衍生的组分中对最近合成的G(o)1α进行免疫沉淀,则在细胞质组分中也检测到相当比例的C3S G(o)1α免疫反应性。用百日咳毒素预处理C5B和D3克隆的细胞导致两种细胞类型中G(o)1α细胞群体的完全ADP核糖基化,而不管该多肽在细胞破坏后随后在膜或细胞质组分中是否被发现。相比之下,在百日咳毒素催化的[32P]ADP核糖基化之前分离膜和细胞质组分仅允许对膜相关的G(o)1α(无论是野生型还是C3S突变体)进行修饰。通过将膜与鸟苷5'-[βγ-亚氨基]三磷酸一起孵育,这种标记显著减少。未通过免疫检测到细胞质G蛋白β亚基,并且来自D3细胞的非膜相关C3S G(o)1α在Superose 12凝胶过滤柱上迁移为明显的单体40 kDa蛋白。膜相关的野生型和C3S G(o)1α似乎以相似的亲和力与鸟嘌呤核苷酸相互作用,因为对于两种形式的G(o)1α,鸟嘌呤核苷酸诱导的稳定37 kDa胰蛋白酶片段维持的剂量反应曲线没有改变。用中性1 M羟胺对克隆C5B的膜进行化学脱棕榈酰化导致约25-30%的G(o)1α、Gi2α和Gqα/G11α从膜中释放。对D3细胞进行等效处理导致Gi2α和Gqα/G11α等效释放,但无法导致膜结合的G(o)1α的CS3形式有任何明显释放。